{
  "retracted": false,
  "timestamp": 1229472000000,
  "updates": [
    {
      "timestamp": 1574401483442,
      "identifier": {
        "doi": "10.1038/leu.2008.288"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1038/leu.2008.235"
  },
  "journal": "Leukemia",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum: The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis"
}
